Berit Verbist

Dr. Berit Verbist

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in Otology & Neurotology
Verified
Journal Article
Closed access
BVBerit Verbist
Berit Verbist
MSMargaret W. Skinner
Margaret W. Skinner
LCLawrence T. Cohen
Lawrence T. Cohen
PLPatricia A. Leake
Patricia A. Leake
CJChris James
Chris James
JFJohan HM Frijns
Johan HM Frijns
Hypothesis: An objective cochlear framework, for evaluation of the cochlear anatomy and description of the position of an implanted cochlear implant electrode, would allow the direct comparison of measures performed within the various subdisciplines involved in cochlear implant research. Background: Research on the human cochlear anatomy in relation to tonotopy and cochlear implantation is conducted by specialists from numerous disciplines such as histologists, surgeons, physicists, engineers, audiologists, and radiologists. To allow accurate comparisons between and combinations of previous and forthcoming scientific and clinical studies, cochlear structures and electrode positions must be specified in a consistent manner. Methods: Researchers with backgrounds in the various fields of inner ear research as well as representatives of the different manufacturers of cochlear implants (Advanced Bionics Corp., Med-El, Cochlear Corp.) were involved in consensus meetings held in Dallas, March 2005, and Asilomar, August 2005. Existing coordinate systems were evaluated, and requisites for an objective cochlear framework were discussed. Results: The consensus panel agreed upon a 3-dimensional, cylindrical coordinate system of the cochlea using the "Cochlear View" as a basis and choosing a z axis through the modiolus. The zero reference angle was chosen at the center of the round window, which has a close relationship to the basal end of the Organ of Corti. Conclusion: Consensus was reached on an objective cochlear framework, allowing the outcomes of studies from different fields of research to be compared directly.

1 June 2011 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
HJHeidy C.J. Jaspers
Heidy C.J. Jaspers
BVBerit Verbist
Berit Verbist
RSRafke Schoffelen
Rafke Schoffelen
VMVera Mattijssen
Vera Mattijssen
PSPiet J. Slootweg
Piet J. Slootweg
CHCarla M.L. van Herpen
Carla M.L. van Herpen

15 July 2009 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
FCF. M. Cox
F. M. Cox
JVJ. J. Verschuuren
J. J. Verschuuren
BVBerit Verbist
Berit Verbist
ENE. H. Niks
E. H. Niks
AWA. R. Wintzen
A. R. Wintzen
UBU. A. Badrising
U. A. Badrising
Dysphagia is an important yet inconsistently recognized symptom of inclusion body myositis (IBM). It can be disabling and potentially life-threatening. We studied the prevalence and symptom-sign correlation of dysphagia. Fifty-seven IBM patients were interviewed using a standard questionnaire for dysphagia and 43 of these underwent swallowing videofluoroscopy (VFS). Symptoms of dysphagia were present in 37 of 57 patients (65%). Nevertheless, only 17 of these patients (46%) had previously and spontaneously complained about swallowing to their physicians. Both symptoms of impaired propulsion (IP) (59%) and aspiration-related symptoms (52%) were frequently mentioned. Swallowing abnormalities on VFS were present in 34 of 43 patients (79%) with IP of the bolus in 77% of this group. The reported feeling of IP was confirmed by VFS in 92% of these patients. Dysphagia in IBM is common but underreported by the vast majority of patients if not specifically asked for. In practice, two questions reliably predict the presence of IP on VFS: ‘Does food get stuck in your throat’ and ‘Do you have to swallow repeatedly in order to get rid of food’. These questions are an appropriate means in selecting IBM patients for further investigation through VFS and eventual treatment.

1 June 2009 in Otology & Neurotology
Verified
Journal Article
Closed access
BVBerit Verbist
Berit Verbist
Luca FerrariniLuca Ferrarini
Luca Ferrarini
JBJeroen J. Briaire
Jeroen J. Briaire
AZAndrzej Zarowski
Andrzej Zarowski
FAFaiza Admiraal-Behloul
Faiza Admiraal-Behloul
JFJohan HM Frijns
Johan HM Frijns
Hypothesis: The goal of this study is to analyze the 3-dimensional anatomy of the cochlear spiral and to investigate the consequences of its course to insertion trauma during cochlear implantation. Background: Insertion trauma in cochlear implant surgery is a feared surgical risk, potentially causing neural degeneration and altered performance of the implant. In literature, insertion trauma is reported to occur at specific locations. This has been ascribed to surgical technique and electrode design in relation to the size of the scala tympani. This study investigates whether there is an underlying anatomic substrate serving as a potential source for insertion trauma at these specific locations. Methods: The 3-dimensional path of the cochlear spiral of 8 human temporal bones was determined by segmentation, skeletonization, distance mapping, and wave propagation technique applied on microcomputer tomography images. Potential pressure points along this path were estimated with linear regression. Results: The cochlear lumen shows a noncontinuous spiraling path leading to potential pressure points during cochlear implantation at the basilar membrane in the region of 180 to 225 (12-14 mm) and 725 degrees (22-26 mm) and at the floor of the scala tympani around 0 to 90, 225 to 270, and 405 to 450 degrees. Conclusion: Our data favor the idea that the intrinsic 3-dimensional cochlear morphology contributes to the risk for insertion trauma during cochlear implantation at specific locations.

1 January 2014 in Ear & Hearing
Verified
Journal Article
Closed access
KMKim S. van der Marel
Kim S. van der Marel
JBJeroen J. Briaire
Jeroen J. Briaire
RWRon Wolterbeek
Ron Wolterbeek
JSJorien Snel-Bongers
Jorien Snel-Bongers
BVBerit Verbist
Berit Verbist
JFJohan HM Frijns
Johan HM Frijns
Objectives: To define a minimal set of descriptive parameters for cochlear morphology and study its influence on the cochlear implant electrode position in relation to surgical insertion distance. Design: Cochlear morphology and electrode position were analyzed using multiplanar reconstructions of the pre- and postoperative CT scans in a population of 336 patients (including 26 bilaterally implanted ones) with a CII HiFocus1 or HiRes90K HiFocus1J implant. Variations in cochlear diameter and cochlear canal size were analyzed. The relationship between the outer and inner walls was investigated. Size differences based on sex, age, and ear side were investigated using linear mixed models. Two new methods, spiral fitting and principal component analysis, were proposed to describe cochlear shape, and the goodness of fit was investigated. The relationship between cochlear shape and electrode position, in terms of modiolus proximity and insertion depth, was analyzed using clustering, one-way analysis of variance (ANOVA) and simple linear regression analysis. Results: Large variations in cochlear morphology were found, with cochlear canal sizes ranging from 0.98 to 2.96 mm and average cochlear diameters between 8.85 and 5.92 mm (with standard deviations of around 0.4 mm). The outer and inner walls were significantly correlated (p < 0.01), and a size difference of 4% in favor of males was found. Spiral fitting shows good alignment of the true measurements, with residuals having a mean of 0.01 mm and a standard deviation of 0.29 mm. Principal component analysis (PCA) showed that the use of one component, which describes size, is sufficient to explain 93.6% of the cochlear shape variance. A significant sex difference was also found with spiral fitting and PCA. Cochlear size was found to have a significant influence on modiolus proximity and insertion depth of the electrode (p < 0.01). Cochlear size explained around 13% of the variance in electrode position. When cochlear size was combined with surgical insertion, more than 81% of the variance in insertion depth can be explained. Conclusions: This study demonstrates a large variety in cochlear morphology, which significantly impacts electrode position in terms of modiolus proximity and insertion depth. The effect size is, however, relatively small compared with surgical insertion distance. PCA is shown to be an accurate reduction method for describing cochlear shape.

6 February 2020 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
JSJ.M. van Steekelenburg
J.M. van Steekelenburg
AWA. van Weijnen
A. van Weijnen
LPL.M.H. de Pont
L.M.H. de Pont
OVOnno Vijlbrief
Onno Vijlbrief
CBC.C. Bommeljé
C.C. Bommeljé
SHS. Hammer
S. Hammer
BACKGROUND AND PURPOSE: Ménière disease is characterized by endolymphatic hydrops, whereas perilymphatic enhancement on MR imaging has been suggested to be of additional value in diagnosing Ménière disease. This study evaluates the presence of endolymphatic hydrops and perilymphatic enhancement in patients with Ménière disease and with other vertigo-associated inner ear pathology. MATERIALS AND METHODS: A 3D-FLAIR sequence 4 hours after intravenous gadolinium injection was performed to visualize the endolymph and perilymph in 220 patients suspected of having Ménière disease. Patients’ ears were retrospectively categorized as having Ménière disease (probable or definite) or other vertigo-associated inner ear pathology not attributable to Ménière disease. Endolymphatic hydrops was evaluated using a visual classification system, and perilymphatic enhancement was scored both visually and quantitatively. RESULTS: Endolymphatic hydrops was present in 137 (91.9%) of the definite Ménière disease ears and in 9 (7.0%) of the ears with other vertigo-associated inner ear pathology (P < .001). The combination of endolymphatic hydrops and visually increased perilymphatic enhancement was present in 122 (81.9%) definite Ménière disease ears compared with 4 (3.1%) ears with other vertigo-associated inner ear pathology (P < .001). This combination increases the positive predictive value from 0.94 for endolymphatic hydrops and 0.91 for perilymphatic enhancement to 0.97. The addition of measured perilymphatic enhancement leads to a moderate decrease in sensitivity from 0.92 for endolymphatic hydrops to 0.86. CONCLUSIONS: The combination of perilymphatic enhancement and endolymphatic hydrops in patients suspected of having Ménière disease increases the positive predictive value in the diagnosis of definite Ménière disease.